News

Print

Osborne Clarke has advised Imperial Innovations Group plc on a £3 million funding round in Abingdon Health

16 Apr 2012


Osborne Clarke has advised Imperial Innovations Group plc on a £3 million funding round in Abingdon Health, a specialist medical diagnostics company.

Imperial led the round, which also included funding from private investors.

Abingdon will use the funds to take a controlling interest in disposable diagnostic device provider  Molecular Vision, as well as investing in other projects.

The OC team advising Imperial was led by Private Equity partner Robert Wood.

Contacts

If you want to find out more about any of the issues in this publication/press release please get in touch with one of our experts.

Subscribe here for updates